Top

Published in:

Open Access 01-06-2016 | Review of the literature

New developments in the pathology of malignant lymphoma. A review of the literature published from January–April 2016

Author: J. Han van Krieken

Published in: Journal of Hematopathology | Issue 2/2016

Excerpt

Science and knowledge progress rapidly. How to make something out of huge data sets, large amounts of information that comes on a daily base to us through various sources? Although the bias of hypothesis-driven research may indeed prevent to discover the unusual, the downside of it is that just finding significant correlations overflows the literature (see also the editorial in this issue; [1]). This review gives some examples of the different approaches to science, and it is up the reader to draw conclusions. …

van Krieken (2016) Are we making progress? J. Hematopathol

de Oliveira KA, Kaergel E, Heinig M, Fontaine JF, Patone G, Muro EM, Mathas S, Hummel M, Andrade-Navarro MA, Hübner N, Scheidereit C (2016) A roadmap of constitutive NF-kB activity in Hodgkin lymphoma: dominant roles of p50 and p52 revealed by genome-wide analyses. Genome Med 8:28CrossRefPubMedPubMedCentral

Paydas S, Acikalin A, Ergin M, Celik H, Yavuz B, Tanriverdi K (2016) Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables. Med Oncol 33:34CrossRefPubMed

Gossmann J, Stolte M, Lohoff M, Yu P, Moll R, Finkernagel F, Garn H, Brendel C, Bittner A, Neubauer A, Huynh MQ (2016) A gain-of-function mutation in the Plcg2 gene protects mice from helicobacter felis-induced gastric MALT lymphoma. PLoS One 11, e0150411CrossRefPubMedPubMedCentral

Cui Y, Sun Z, Li X, Leng C, Zhang L, Fu X, Li L, Zhang X, Chang YU, Nan F, Li Z, Yan J, Zhang M, Li W, Wang G, Zhang D, Ma Y (2016) Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphoma. Oncol Lett 11:693–698PubMed

Broutier L, Creveaux M, Vial J, Tortereau A, Delcros JG, Chazot G, McCarron MJ, Léon S, Pangault C, Gadot N, Colombe A, Boulland ML, Blachier J, Marie JC, Traverse-Glehen A, Donzé O, Chassagne-Clément C, Salles G, Tarte K, Mehlen P, Castets M (2016) Targeting netrin-1/DCC interaction in diffuse large B-cell and mantle cell lymphomas. EMBO Mol Med 8:96–104CrossRefPubMedPubMedCentral

Dekker JD, Park D, Shaffer AL 3rd, Kohlhammer H, Deng W, Lee BK, Ippolito GC, Georgiou G, Iyer VR, Staudt LM, Tucker HO (2016) Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1. Proc Natl Acad Sci U S A 113:E577–E586CrossRefPubMed

Hafsi S, Candido S, Maestro R, Falzone L, Soua Z, Bonavida B, Spandidos DA, Libra M (2016) Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt’s lymphoma: a computational study. Oncol Lett 11:1021–1025PubMed

Nairismägi ML, Tan J, Lim JQ, Nagarajan S, Ng CC, Rajasegaran V, Huang D, Lim WK, Laurensia Y, Wijaya GC, Li ZM, Cutcutache I, Pang WL, Thangaraju S, Ha J, Khoo LP, Chin ST, Dey S, Poore G, Tan LH, Koh HK, Sabai K, Rao HL, Chuah KL, Ho YH, Ng SB, Chuang SS, Zhang F, Liu YH, Pongpruttipan T, Ko YH, Cheah PL, Karim N, Chng WJ, Tang T, Tao M, Tay K, Farid M, Quek R, Rozen SG, Tan P, Teh BT, Lim ST, Tan SY, Ong CK (2016) JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma. Leukemia. doi:10.1038/leu.2016.13 PubMed

10.

Hao Z, Cairns RA, Inoue S, Li WY, Sheng Y, Lemonnier F, Wakeham A, Snow BE, Dominguez-Brauer C, Ye J, Larsen DM, Straley KS, Tobin ER, Narayanaswamy R, Gaulard P, Mak TW (2016) Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered mice. Proc Natl Acad Sci U S A 113:1387–1392CrossRefPubMedPubMedCentral

11.

Malcolm TI, Villarese P, Fairbairn CJ, Lamant L, Trinquand A, Hook CE, Burke GA, Brugières L, Hughes K, Payet D, Merkel O, Schiefer AI, Ashankyty I, Mian S, Wasik M, Turner M, Kenner L, Asnafi V, Macintyre E, Turner SD (2016) Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress. Nat Commun 7:10087CrossRefPubMedPubMedCentral

12.

Perry AM, Perner Y, Diebold J, Nathwani BN, MacLennan KA, Müller-Hermelink HK, Bast M, Boilesen E, Armitage JO, Weisenburger DD (2016) Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from the international non-Hodgkin lymphoma classification project. Br J Haematol 172:716–723CrossRefPubMed

13.

O’Suoji C, Welch JJ, Perkins SL, Smith LM, Weitzman S, Simko SJ, Galardy PJ, Bollard CM, Gross TG, Termuhlen AM (2016) Rare pediatric non-Hodgkin lymphomas: a report from children’s oncology group study ANHL 04B1. Pediatr Blood Cancer 63:794–800CrossRefPubMed

14.

Strobbe L, Valke LL, Diets IJ, van den Brand M, Aben K, Raemaekers JM, Hebeda KM, van Krieken JH (2016) A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma. Ann Hematol 95:417–423CrossRefPubMedPubMedCentral

15.

Kenderian SS, Habermann TM, Macon WR, Ristow KM, Ansell SM, Colgan JP, Johnston PB, Inwards DJ, Markovic SN, Micallef IN, Thompson CA, Porrata LF, Martenson JA, Witzig TE, Nowakowski GS (2016) Large B-cell transformation in nodular lymphocyte predominant Hodgkin lymphoma: forty-year experience from a single institution. Blood 127:1960–1966CrossRefPubMed

16.

Castelli R, Wu MA, Arquati M, Zanichelli A, Suffritti C, Rossi D, Cicardi M (2016) High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency. Br J Haematol 172:902–908CrossRefPubMed

17.

Gong QX, Lu TX, Liu C, Wang Z, Liang JH, Xu W, Li JY, Zhang ZH, Chen Q (2015) Prevalence and clinicopathologic features of CD30-positive de novo diffuse large B-cell lymphoma in Chinese patients: a retrospective study of 232 cases. Int J Clin Exp Pathol 8:15825–15835PubMedPubMedCentral

18.

van den Brand M, Balagué O, van Cleef PH, Groenen PJ, Hebeda KM, de Jong D, van Krieken JH (2015) A subset of low-grade B cell lymphomas with a follicular growth pattern but without a BCL2 translocation shows features suggestive of nodal marginal zone lymphoma. J Hematop 9:3–8CrossRefPubMedPubMedCentral

19.

Batlle-López A, González de Villambrosía S, Mazorra F, Malatxeberria S, Sáez A, Montalban C, Sánchez L, Garcia JF, González-Barca E, López A, Ruiz-Marcellan MC, Mollejo M, Grande C, Richards KL, Hsi ED, Tzankov A, Visco C, Xu-Monette ZY, Cao X, Young KH, Angel Piris M, Conde E, Montes-Moreno S (2016) Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker. Oncotarget. doi:10.18632/oncotarget.7495 PubMed

20.

Lu TX, Miao Y, Wu JZ, Gong QX, Liang JH, Wang Z, Wang L, Fan L, Hua D, Chen YY, Xu W, Zhang ZH, Li JY (2016) The distinct clinical features and prognosis of the CD10(+)MUM1(+) and CD10(−)Bcl6(−)MUM1(−) diffuse large B-cell lymphoma. Sci Rep 6:20465. doi:10.1038/srep20465 CrossRefPubMedPubMedCentral

21.

Roth CG, Gillespie-Twardy A, Marks S, Agha M, Raptis A, Hou JZ, Farah R, Lin Y, Qian Y, Pantanowitz L, Boyiadzis M (2016) Flow cytometric evaluation of double/triple hit lymphoma. Oncol Res 23(3):137–146CrossRefPubMed

22.

Moench L, Sachs Z, Aasen G, Dolan M, Dayton V, Courville EL (2016) Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges. Leuk Lymphoma 18:1–10CrossRef

23.

Tanaka T, Yamamoto H, Elsayed AA, Satou A, Asano N, Kohno K, Kinoshita T, Niwa Y, Goto H, Nakamura S, Kato S (2016) Clinicopathologic spectrum of gastrointestinal T-cell lymphoma: reappraisal based on T-cell receptor immunophenotypes. Am J Surg Pathol 40:777–785CrossRefPubMed

24.

Kim EK, Yoon SO, Kim SH, Yang WI, Cho YA, Kim SJ (2016) Upregulated neuro-oncological ventral antigen 1 (NOVA1) expression is specific to mature and immature T- and NK-cell lymphomas. J Pathol Transl Med 50:104–112CrossRefPubMedPubMedCentral

25.

Dobashi A, Tsuyama N, Asaka R, Togashi Y, Ueda K, Sakata S, Baba S, Sakamoto K, Hatake K, Takeuchi K (2016) Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type. Genes Chromosom Cancer 55:460–471CrossRefPubMed

26.

Yoshida N, Miyoshi H, Kato T, Sakata-Yanagimoto M, Niino D, Taniguchi H, Moriuchi Y, Miyahara M, Kurita D, Sasaki Y, Shimono J, Kawamoto K, Utsunomiya A, Imaizumi Y, Seto M, Ohshima K (2016) CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis. J Pathol 238:621–626CrossRefPubMed

27.

Lee WJ, Moon IJ, Lee SH, Won CH, Chang SE, Choi JH, Chan Moon K, Park CS, Huh J, Lee MW (2016) Cutaneous anaplastic large-cell lymphoma (ALCL): a comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site. J Am Acad Dermatol. doi:10.1016/j.jaad.2015.12.053

28.

LeBlanc RE, Tavallaee M, Kim YH, Kim J (2016) Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis. Am J Surg Pathol 40:745–754CrossRefPubMed

29.

Lorenzi L, Lonardi S, Essatari MH, Pellegrini V, Fisogni S, Gazzola A, Agostinelli C, Vermi W, Rossi G, Massarelli G, Pileri SA, Facchetti F (2016) Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of “germinotropic” lymphoproliferative disorder. Virchows Arch 468:441–450CrossRefPubMed

30.

Rovira J, Karube K, Valera A, Colomer D, Enjuanes A, Colomo L, Martínez-Trillos A, Giné E, Dlouhy I, Magnano L, Delgado J, Martínez A, Villamor N, Campo E, López-Guillermo A (2016) MYD88 L265P mutations, but no other variants, identify a subpopulation of DLBCL patients of activated B-cell origin, extranodal involvement, and poor outcome. Clin Cancer Res 22(11):2755–2764CrossRefPubMed

31.

Taniguchi K, Takata K, Chuang SS, Miyata-Takata T, Sato Y, Satou A, Hashimoto Y, Tamura M, Nagakita K, Ohnishi N, Noujima-Harada M, Tabata T, Kikuti YY, Maeda Y, Nakamura N, Tanimoto M, Yoshino T (2016) Frequent MYD88 L265P and CD79B mutations in primary breast diffuse large B-cell lymphoma. Am J Surg Pathol 40:324–334CrossRefPubMed

32.

Finalet Ferreiro J, Morscio J, Dierickx D, Vandenberghe P, Gheysens O, Verhoef G, Zamani M, Tousseyn T, Wlodarska I (2016) EBV-positive and EBV-negative posttransplant diffuse large B cell lymphomas have distinct genomic and transcriptomic features. Am J Transplant 16(2):414–425CrossRefPubMed

33.

Bermudez G, González de Villambrosía S, Martínez-López A, Batlle A, Revert-Arce JB, Cereceda Company L, Ortega Bezanilla C, Piris MA, Montes-Moreno S (2016) Incidental and isolated follicular lymphoma in situ and mantle cell lymphoma in situ lack clinical significance. Am J Surg Pathol

34.

Nybakken GE, Bala R, Gratzinger D, Jones CD, Zehnder JL, Bangs CD, Cherry A, Warnke RA, Natkunam Y (2016) Isolated follicles enriched for centroblasts and lacking t(14;18)/BCL2 in lymphoid tissue: diagnostic and clinical implications. PLoS One 11, e0151735CrossRefPubMedPubMedCentral

35.

van den Brand M, Garcia-Garcia M, Mathijssen JJ, Colomo L, Groenen PJ, Serrano S, Krieken JH (2016) Partial lack of BCL2 in follicular lymphoma: an unusual immunohistochemical staining pattern explained by ongoing BCL2 mutation. Pathol Res Pract 212:148–150CrossRefPubMed

36.

Jain D, Mallick SR, Singh V, Singh G, Mathur SR, Sharma MC (2016) Napsin A expression in anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a diagnostic pitfall. Appl Immunohistochem Mol Morphol 24(5):e34–e40CrossRefPubMed

37.

Hoster E, Rosenwald A, Berger F, Bernd HW, Hartmann S, Loddenkemper C, Barth TF, Brousse N, Pileri S, Rymkiewicz G, Kodet R, Stilgenbauer S, Forstpointner R, Thieblemont C, Hallek M, Coiffier B, Vehling-Kaiser U, Bouabdallah R, Kanz L, Pfreundschuh M, Schmidt C, Ribrag V, Hiddemann W, Unterhalt M, Kluin-Nelemans JC, Hermine O, Dreyling MH, Klapper W (2016) Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European mantle cell lymphoma network. J Clin Oncol 34:1386–1394CrossRefPubMed

38.

Choi CH, Park YH, Lim JH, Choi SJ, Kim L, Park IS, Han JY, Kim JM, Chu YC (2016) Prognostic implication of semi-quantitative immunohistochemical assessment of CD20 expression in diffuse large B-cell lymphoma. J Pathol Transl Med 50:96–103CrossRefPubMedPubMedCentral

39.

Yabe M, Medeiros LJ, Tang G, Wang SA, Ahmed S, Nieto Y, Hu S, Bhagat G, Oki Y, Patel KP, Routbort M, Luthra R, Fanale MA, Bueso-Ramos CE, Jorgensen JL, Vega F, Chen W, Hoehn D, Konoplev S, Milton DR, Wistuba I, Li S, You MJ, Young KH, Miranda RN (2016) Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases. Am J Surg Pathol 40:676–688CrossRefPubMed

40.

van Krieken JH (2016) New developments in the pathology of malignant lymphoma. A review of the literature published from September 2015–December 2015. J Hematop 9(1):19–27CrossRefPubMedPubMedCentral

41.

Cho YA, Yang WI, Song JW, Min YH, Yoon SO (2016) The prognostic significance of monoclonal immunoglobulin gene rearrangement in conjunction with histologic B-cell aggregates in the bone marrow of patients with diffuse large B-cell lymphoma. Cancer Med. doi:10.1002/cam4.679 PubMedCentral

42.

Di Martino S, Catapano O, Siesto SR, Di Paolo M, Pugliese S, Morelli CD, Fiorica F, Varriale E, Di Francia R, Abbadessa A (2015) Quantitative PCR detection of t(11;14) bcl-1/JH in mantle cell lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples. Eur Rev Med Pharmacol Sci 19:4801–4810PubMed

43.

Aesif SW, Kuipers I, DePalma L (2016) The relevance of tissue thiol histochemistry to diagnostic hematopathology. Biotech Histochem 91:255–262CrossRefPubMed

44.

Camus V, Sarafan-Vasseur N, Bohers E, Dubois S, Mareschal S, Bertrand P, Viailly PJ, Ruminy P, Maingonnat C, Lemasle E, Stamatoullas A, Picquenot JM, Cornic M, Beaussire L, Bastard C, Frebourg T, Tilly H, Jardin F (2016) Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma. Leuk Lymphoma :1–9

45.

Lee SE, Kang SY, Yoo HY, Kim SJ, Kim WS, Ko YH (2016) Clonal relationships in recurrent B-cell lymphomas. Oncotarget. doi:10.18632/oncotarget.7132

46.

Jiang Y, Nie K, Redmond D, Melnick AM, Tam W, Elemento O (2015) VDJ-Seq: Deep sequencing analysis of rearranged immunoglobulin heavy chain gene to reveal clonal evolution patterns of B cell lymphoma. J Vis Exp :e53215. doi:10.9081/rt.2015.6084

47.

Dubois S, Viailly PJ, Mareschal S, Bohers E, Bertrand P, Ruminy P, Maingonnat C, Jais JP, Peyrouze P, Figeac M, Molina TJ, Desmots F, Fest T, Haioun C, Lamy T, Copie-Bergman C, Briere J, Petrella T, Canioni D, Fabiani B, Coiffier B, Delarue R, Peyrade F, Bosly A, Andre M, Ketterer N, Salles G, Tilly H, Leroy K, Jardin F (2016) Next generation sequencing in diffuse large B cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study. Clin Cancer Res. doi:10.1158/1078-0432CCR-15-2005

48.

Chapuy B, Cheng H, Watahiki A, Ducar MD, Tan Y, Chen L, Roemer MG, Ouyang J, Christie AL, Zhang L, Gusenleitner D, Abo RP, Farinha P, von Bonin F, Thorner AR, Sun HH, Gascoyne RD, Pinkus GS, van Hummelen P, Wulf GG, Aster JC, Weinstock DM, Monti S, Rodig SJ, Wang Y, Shipp MA (2016) Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biologic heterogeneity of the disease. Blood 127(18):2203–2213CrossRefPubMed

49.

Wu R, Nijland M, Rutgers B, Veenstra R, Langendonk M, van der Meeren LE, Kluin PM, Li G, Diepstra A, Chiu JF, van den Berg A, Visser L (2016) Proteomics based identification of proteins with deregulated expression in B cell lymphomas. PLoS One 11(1), e0146624CrossRefPubMedPubMedCentral

50.

Fauzi MF, Pennell M, Sahiner B, Chen W, Shana’ah A, Hemminger J, Gru A, Kurt H, Losos M, Joehlin-Price A, Kavran C, Smith SM, Nowacki N, Mansor S, Lozanski G, Gurcan MN (2015) Classification of follicular lymphoma: the effect of computer aid on pathologists grading. BMC Med Inform Decis Mak 15:115CrossRefPubMedPubMedCentral

Title: New developments in the pathology of malignant lymphoma. A review of the literature published from January–April 2016
Author: J. Han van Krieken
Publication date: 01-06-2016
Publisher: Springer Berlin Heidelberg
Published in: Journal of Hematopathology / Issue 2/2016
Print ISSN: 1868-9256
Electronic ISSN: 1865-5785
DOI: https://doi.org/10.1007/s12308-016-0277-4

ACC 2024 Congress

Springer Medicine

New developments in the pathology of malignant lymphoma. A review of the literature published from January–April 2016

Excerpt

ACC 2024 Congress

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2016

PAX stains in hematologic malignancies, a diagnostic pitfall: a comparative study evaluating monoclonal PAX8s, polyclonal PAX2, and PAX5

Are we making progress?

Flow cytometry detection of reactive plasmacytosis and HRS-like cells as a challenging initial finding in angioimmunoblastic T cell lymphoma

Significance of CD10-positive clonal B cell populations identified by flow cytometry in histologically benign gastric biopsies

How we do: optimizing bone marrow biopsy logistics for sign-out within 2 days

An unusual case of co-existing classic mantle cell lymphoma and transformed lymphoma with Burkitt-like features with leukemic presentation